Investigating Liquid–Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Zipei Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Liquid–Liquid Phase Separation (LLPS) refers to the separation of biomacromolecules into separate liquid phases within the cells, plays a critical role in lung cancer pathogenesis. Using machine learning, we developed an LLPS‐associated signature (LLPSAS) based on 79 key genes. The LLPSAS demonstrated superior prognostic performance compared to 140 existing lung adenocarcinoma (LUAD) prognostic models. Patients stratified by LLPSAS risk scores revealed significantly lower overall survival in the high‐risk group. Comparative analysis between the high‐risk and low‐risk groups showed distinct pathway enrichment, genomic alterations, tumour immune microenvironment (TIME) profiles, immunotherapy responses and drug sensitivities. The low‐risk group exhibited an inflamed TIME, suggesting potentially better immunotherapy response. Furthermore, potential effective small molecule drugs were identified for high‐risk patients. Finally, immunohistochemistry confirmed upregulation of LLPS‐associated proteins (PLK1, HMMR, PRC1) in LUAD tissues, and immunofluorescence validated their LLPS occurrence. Conclusively, the LLPSAS provides a valuable tool for LUAD prognosis and treatment optimisation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Oncology, the First Medical Center, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, China.
- Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical Univer…
- Department of Oncology, The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research, Nanjing, China.
ORCID-Profile: Zipei Song, Pengpeng Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, Z., Li, Y., Zhang, P., Wei, K., Zhu, M., Wang, Y., Li, Z., Chen, L., & Zheng, J. (2025). Investigating Liquid–Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70807
Vancouver
Song Z, Li Y, Zhang P, Wei K, Zhu M, Wang Y, et al. Investigating Liquid–Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70807
BibTeX
@article{Song2025,
author = {Song, Zipei and Li, Yuting and Zhang, Pengpeng and Wei, Ke and Zhu, Miaolin and Wang, Yuheng and Li, Zhihua and Chen, Liang and Zheng, Jianan},
title = {Investigating Liquid–Liquid Phase Separation in Lung Adenocarcinoma to Improve Prognostic Accuracy and Treatment Efficacy},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70807}
}
EUVIMED